JP2020011070A - インビボ検体モニタリング環境における電力供給方法、およびインビボ検体モニタリングシステム - Google Patents
インビボ検体モニタリング環境における電力供給方法、およびインビボ検体モニタリングシステム Download PDFInfo
- Publication number
- JP2020011070A JP2020011070A JP2019142804A JP2019142804A JP2020011070A JP 2020011070 A JP2020011070 A JP 2020011070A JP 2019142804 A JP2019142804 A JP 2019142804A JP 2019142804 A JP2019142804 A JP 2019142804A JP 2020011070 A JP2020011070 A JP 2020011070A
- Authority
- JP
- Japan
- Prior art keywords
- power
- sensor
- sensor controller
- wireless communications
- supply
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 102
- 238000012544 monitoring process Methods 0.000 title claims abstract description 79
- 238000001727 in vivo Methods 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims description 85
- 238000004891 communication Methods 0.000 claims abstract description 202
- 230000007704 transition Effects 0.000 claims description 44
- 238000012546 transfer Methods 0.000 claims description 11
- 239000003990 capacitor Substances 0.000 claims description 6
- 230000001186 cumulative effect Effects 0.000 claims 2
- 230000005540 biological transmission Effects 0.000 abstract description 49
- 230000005291 magnetic effect Effects 0.000 abstract description 24
- 230000003287 optical effect Effects 0.000 description 41
- 230000004044 response Effects 0.000 description 36
- 230000004913 activation Effects 0.000 description 28
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 26
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 26
- 230000006870 function Effects 0.000 description 26
- 239000008103 glucose Substances 0.000 description 26
- 238000010586 diagram Methods 0.000 description 24
- 238000012545 processing Methods 0.000 description 22
- 239000012992 electron transfer agent Substances 0.000 description 19
- 229920000642 polymer Polymers 0.000 description 18
- 239000000853 adhesive Substances 0.000 description 17
- 230000001070 adhesive effect Effects 0.000 description 17
- 238000007726 management method Methods 0.000 description 17
- 238000012790 confirmation Methods 0.000 description 15
- 241000894007 species Species 0.000 description 15
- 230000008569 process Effects 0.000 description 14
- 230000015654 memory Effects 0.000 description 13
- 239000003054 catalyst Substances 0.000 description 12
- 238000003860 storage Methods 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 229910052762 osmium Inorganic materials 0.000 description 11
- 230000000875 corresponding effect Effects 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 239000003446 ligand Substances 0.000 description 9
- 238000000338 in vitro Methods 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 230000009471 action Effects 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- -1 etc.) Chemical compound 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 210000003722 extracellular fluid Anatomy 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 3
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 3
- 230000003044 adaptive effect Effects 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 125000002524 organometallic group Chemical group 0.000 description 3
- 229920000075 poly(4-vinylpyridine) Polymers 0.000 description 3
- 229910052707 ruthenium Inorganic materials 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 2
- 229940075397 calomel Drugs 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000006056 electrooxidation reaction Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 2
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 2
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 2
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 2
- 238000009432 framing Methods 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 239000004984 smart glass Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 238000012384 transportation and delivery Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 150000005045 1,10-phenanthrolines Chemical class 0.000 description 1
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 1
- ZPGVCQYKXIQWTP-UHFFFAOYSA-N 4,7-dimethoxy-1,10-phenanthroline Chemical compound C1=CC2=C(OC)C=CN=C2C2=C1C(OC)=CC=N2 ZPGVCQYKXIQWTP-UHFFFAOYSA-N 0.000 description 1
- JIVLDFFWTQYGSR-UHFFFAOYSA-N 4,7-dimethyl-[1,10]phenanthroline Chemical compound C1=CC2=C(C)C=CN=C2C2=C1C(C)=CC=N2 JIVLDFFWTQYGSR-UHFFFAOYSA-N 0.000 description 1
- IMEVSAIFJKKDAP-UHFFFAOYSA-N 4-methoxy-2-(4-methoxypyridin-2-yl)pyridine Chemical compound COC1=CC=NC(C=2N=CC=C(OC)C=2)=C1 IMEVSAIFJKKDAP-UHFFFAOYSA-N 0.000 description 1
- NBPGPQJFYXNFKN-UHFFFAOYSA-N 4-methyl-2-(4-methylpyridin-2-yl)pyridine Chemical compound CC1=CC=NC(C=2N=CC=C(C)C=2)=C1 NBPGPQJFYXNFKN-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 230000005355 Hall effect Effects 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
- 102100038358 Prostate-specific antigen Human genes 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 108090001027 Troponin Proteins 0.000 description 1
- 239000004775 Tyvek Substances 0.000 description 1
- 229920000690 Tyvek Polymers 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940015047 chorionic gonadotropin Drugs 0.000 description 1
- 150000001869 cobalt compounds Chemical class 0.000 description 1
- AVINMTZQCQURBJ-UHFFFAOYSA-N cobalt;2-pyridin-2-ylpyridine Chemical group [Co].N1=CC=CC=C1C1=CC=CC=N1 AVINMTZQCQURBJ-UHFFFAOYSA-N 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013523 data management Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000012938 design process Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229960000648 digitoxin Drugs 0.000 description 1
- WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- IXZISFNWUWKBOM-ARQDHWQXSA-N fructosamine Chemical compound NC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O IXZISFNWUWKBOM-ARQDHWQXSA-N 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- RSAZYXZUJROYKR-UHFFFAOYSA-N indophenol Chemical compound C1=CC(O)=CC=C1N=C1C=CC(=O)C=C1 RSAZYXZUJROYKR-UHFFFAOYSA-N 0.000 description 1
- 238000011423 initialization method Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- XJCPMUIIBDVFDM-UHFFFAOYSA-M nile blue A Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4[O+]=C3C=C(N)C2=C1 XJCPMUIIBDVFDM-UHFFFAOYSA-M 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000004424 polypyridyl Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003623 transition metal compounds Chemical class 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229960005080 warfarin Drugs 0.000 description 1
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6832—Means for maintaining contact with the body using adhesives
- A61B5/6833—Adhesive patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6848—Needles
- A61B5/6849—Needles in combination with a needle set
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0209—Operational features of power management adapted for power saving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0266—Operational features for monitoring or limiting apparatus function
- A61B2560/0271—Operational features for monitoring or limiting apparatus function using a remote monitoring unit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02D—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN INFORMATION AND COMMUNICATION TECHNOLOGIES [ICT], I.E. INFORMATION AND COMMUNICATION TECHNOLOGIES AIMING AT THE REDUCTION OF THEIR OWN ENERGY USE
- Y02D30/00—Reducing energy consumption in communication networks
- Y02D30/70—Reducing energy consumption in communication networks in wireless communication networks
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Optics & Photonics (AREA)
- Computer Networks & Wireless Communication (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Selective Calling Equipment (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
Abstract
Description
光エネルギーまたは磁気エネルギー等の外部刺激を用いた電力状態の変更の例示的な実施形態
先に述べたように、製造プロセスの完了後の、例えば出荷待ちの間、“棚に残っている”間、または別様で顧客または被験者による最初の使用を待つ間等、システム100が用いられない長い期間が生じる場合がある。この期間に、センサ制御装置102は、内蔵電源260の寿命を節約するために、最小限の電力を用い得る。センサ制御装置102は低電力状態であり得るか、または、電源260がセンサ電子装置250の残りの部分から電気的に絶縁されている場合には、完全に非作動にされ得る。製造後の開始、即ち作動が無線信号を用いて行われる実施形態は、本明細書に組み込まれる米国特許仮出願シリアル番号第61/817,839号明細書に記載されている。以下の実施形態は、上記の無線に基づく実施形態と自由に置き換えることができる。
無線送信を用いて電力状態を変更するための例示的な実施形態
ここで、センサ制御装置102の作動、センサ制御装置102との通信の確立、および/または(例えば、前の通信セッションが修了した後の)センサ制御装置102との通信の再確立に用いられ得る更なる実施形態を述べる。これらの実施形態は、読取器装置120からセンサ制御装置102に1以上のRF送信を送信することを含む。幾つかの実施形態では、RF送信は、「Bluetooth」プロトコルに準拠して約2400〜2480メガヘルツ(MHz)(または2.4〜2.48ギガヘルツ(GHz))のRFバンドで送信され、他の実施形態では、通信はNFCプロトコルや他のプロトコルに準拠して行われ、他の周波数帯域が用いられてもよい。
センサ構成
システム100を用いてモニタリングされ得る検体は、アセチルコリン、アミラーゼ、ビリルビン、コレステロール、絨毛性ゴナドトロピン、グリコシル化ヘモグロビン(HbAlc)、クレアチンキナーゼ(例えばCK−MB)、クレアチン、クレアチニン、DNA、フルクトサミン、グルコース、グルコース誘導体、グルタミン、成長ホルモン、ホルモン、ケトン、ケトン体、乳酸、酸素、過酸化物、前立腺特異抗原、プロトロンビン、RNA、甲状腺刺激ホルモン、およびトロポニンが挙げられるが、それらに限定されない。例えば、抗生物質(例えば、ゲンタマイシン、バンコマイシン等)、ジギトキシン、ジゴキシン、乱用薬物、テオフィリン、およびワルファリン等といった薬の濃度がモニタリングされてもよい。2以上の検体をモニタリングする実施形態では、単一のセンサを用いて、同じ電子装置を(例えば、同時に)用い得る複数のセンサを用いて、またはセンサ制御装置102の異なる電子装置を用いて、検体を同時にまたは異なる時間にモニタリングしてもよい。
Claims (20)
- インビボ検体モニタリング環境における電力供給方法であって、
センサ制御装置により、複数の連続ワイヤレス通信を受信するステップであって、該複数の連続ワイヤレス通信の各々がフレームフォーマットのデジタル情報であって、該センサ制御装置が、
ユーザの体内に挿入されている間に検体データを収集するよう構成されているセンサと、
前記センサと結合した検体モニタリング回路と、
前記検体モニタリング回路に動作電力を供給するよう構成されている電源であって、該電源は、前記複数の連続ワイヤレス通信が受信された時には、前記動作電力を前記検体モニタリング回路に供給しないよう構成されている、電源と、
を備えた、ステップと、
前記センサ制御装置により、前記受信した複数の連続ワイヤレス通信からの電力を用いて、前記電源に前記動作電力を前記検体モニタリング回路に供給させるステップと、
を有することを特徴とする方法。 - 前記複数の連続ワイヤレス通信が、複数の近距離通信(NFC)供給コマンドを有し、前記センサ制御装置が前記動作電力を前記検体モニタリング回路に供給するコマンドを
することを特徴とする、請求項1記載の方法。 - 前記複数の近距離通信(NFC)供給コマンドの累積的に受信されたパワーが、前記センサ制御装置により前記複数の近距離通信(NFC)供給コマンドを読み、および前記複数の近距離通信(NFC)供給コマンドに応答するのに用いられた累積的なパワーより大きいことを特徴とする、請求項2記載の方法。
- 前記複数の近距離通信(NFC)供給コマンドの少なくとも1つが、NFCインベントリコマンドであることを特徴とする、請求項3記載の方法。
- 前記複数の連続ワイヤレス通信の累積的に受信されたパワーが、前記センサ制御装置により前記複数の連続ワイヤレス通信に反応するのに用いられた累積的なパワーより大きいことを特徴とする、請求項1記載の方法。
- 前記受信された複数の連続ワイヤレス通信の大部分にとって、該大部分の各々が、コマンド形式の情報を有し、
前記大部分内の前記受信された複数の連続ワイヤレス通信の各々のパワーが、前記センサ制御装置により前記複数の連続ワイヤレス通信を読み、および前記複数の連続ワイヤレス通信に反応するのに消費されたパワーより大きいことを特徴とする、請求項1記載の方法。 - 前記センサ制御装置が、前記電源を前記検体モニタリング回路に選択的に接続するよう構成されている制御回路を更に有することを特徴とする、請求項1記載の方法。
- 前記センサ制御装置により、前記受信された複数の連続ワイヤレス通信からのパワーを用いて、前記電源をして前記検体モニタリング回路に前記動作電力を供給させることが、前記受信された複数の連続ワイヤレス通信からのパワーを用いて、前記制御回路をして前記電源を前記検体モニタリング回路に接続させることを含むことを特徴とする、請求項7記載の方法。
- 前記検体モニタリング回路がプロセッサを有し、
前記受信された複数の連続ワイヤレス通信からのパワーを用いて、前記制御回路をして前記電源を前記検体モニタリング回路に接続させることが、
前記受信された複数の連続ワイヤレス通信からのパワーを前記プロセッサに供給し、
前記プロセッサからの制御信号を前記制御回路に出力し、該出力することが前記制御回路をして前記電源を前記検体モニタリング回路に接続させることを含むことを特徴とする、請求項8記載の方法。 - 前記受信された複数の連続ワイヤレス通信からの力を前記制御回路のコンデンサに充電し、
さらに、前記コンデンサを用いて前記プロセッサに電力を供給することをさらに含むことを特徴とする、請求項8記載の方法。 - センサ制御装置を含むインビボ検体モニタリングシステムであって、
複数の連続的なワイヤレス通信を受信するよう構成されている通信回路であって、該複数の連続的なワイヤレス通信の各々が、デジタルフレーム形式の情報を有する、通信回路と、
ユーザの体内に挿入されている間に検体データを収集するよう構成されているセンサと、
前記センサおよび前記通信回路と結合した検体モニタリング回路と、
前記検体モニタリング回路に作動電力を供給するよう構成されている電源と、
を有し、
前記センサ制御装置は、前記電源が前記動作電力を前記検体モニタリング回路に供給しない第1モードの間、前記複数の連続ワイヤレス通信を受信するよう構成されており、
前記センサ制御装置は、前記電源が前記動作電力を前記検体モニタリング回路に供給しないダイモードの間、前記複数の連続ワイヤレス通信を受信するよう構成されており、
前記センサ制御装置は、前記受信した複数の連続ワイヤレス通信からの電力を用いて、前記電源が前記動作電力を前記検体モニタリング回路に供給するとともに第2モードに移行するようにさせていることを特徴とするシステム。 - 前記複数の連続ワイヤレス通信の各々が、近距離通信(NFC)要求であり、
前記通信回路が、NFCプロトコルに応じて、前記複数の連続ワイヤレス通信を受信するよう構成されていることを特徴とする、請求項11記載のシステム。 - 前記センサ制御回路が、
前記複数の連続ワイヤレス通信の前記複数の連続ワイヤレス通信の内の第1ワイヤレス通信内でNFCインベントリコマンドを解釈するよう構成されているとともに、前記複数の連続ワイヤレス通信の前記複数の連続ワイヤレス通信の内の第2ワイヤレス通信内で前記電源を前記検体モニタリング回路に結合するよう前記センサ制御装置にさせるコマンドを解釈するよう構成されているプロセッサを有することを特徴とする、請求項11記載のシステム。 - 前記センサ制御装置が少なくとも1つのコンデンサを有し、
前記センサ制御装置が、前記少なくとも1つのコンデンサ内で、前記複数の連続ワイヤレス通信からの過剰なパワーを格納するよう構成されていることを特徴とする、請求項11記載のシステム。 - 前記センサ制御装置が前記電源を前記検体モニタリング回路に選択的に接続するよう構成されている制御回路を有することを特徴とする、請求項11記載のシステム。
- 前記第1モードにおいて前記電源が前記検体モニタリング回路に接続しておらず、
前記センサ制御装置が前記受信した複数の連続ワイヤレス通信からのパワーを用いて、前記制御回路が前記電源を前記検体モニタリング回路に接続させるよう構成されていることを特徴とする、請求項15記載のシステム。 - 前記検体モニタリング回路がプロセッサを有し、
前記センサ制御回路が前記受信した複数の連続ワイヤレス通信からのパワーを前記プロセッサに供給するよう構成されていることを特徴とする、請求項16記載のシステム。 - 前記プロセッサが、前記供給されたパワーを用いて、制御信号を前記制御回路に出力して、該出力が前記制御回路をして前記電源を前記検体モニタリング回路に接続させるよう構成されていることを特徴とする、請求項17記載のシステム。
- 読み取り装置をさらに備え、
前記読み取り装置が、前記複数の連続ワイヤレス通信を前記センサ制御装置に送信するとともに、前記センサ制御装置からワイヤレス通信を受信するよう構成されている通信回路を有し、
前記読み取り装置が、前記複数の連続ワイヤレス通信を受信後、ワイヤレス移行コマンドを前記センサ制御装置に送信するようプログラミングされていることを特徴とする、請求項11記載のシステム。 - 前記センサ制御装置が、前記受信された複数の連続ワイヤレス通信からのパワーを用いて、前記ワイヤレス移行コマンドの受信後、前記電源を前記検体モニタリング回路に接続させるよう構成されていることを特徴とする、請求項19記載のシステム。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021148432A JP7566706B2 (ja) | 2013-04-30 | 2021-09-13 | インビボ検体モニタリング環境における電力供給方法 |
JP2023133921A JP2023144126A (ja) | 2013-04-30 | 2023-08-21 | インビボ検体モニタリング環境における電力供給方法 |
JP2024152953A JP2024166235A (ja) | 2013-04-30 | 2024-09-05 | インビボグルコースセンサを有するユーザのインビボグルコースモニタリングのための装置 |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361817839P | 2013-04-30 | 2013-04-30 | |
US61/817,839 | 2013-04-30 | ||
US201361896578P | 2013-10-28 | 2013-10-28 | |
US61/896,578 | 2013-10-28 | ||
US201461973775P | 2014-04-01 | 2014-04-01 | |
US61/973,775 | 2014-04-01 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016511808A Division JP6568517B2 (ja) | 2013-04-30 | 2014-04-29 | ユーザの連続グルコースモニタリングのための装置、およびユーザの連続検体モニタリングのためのセンサ制御装置を準備する方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021148432A Division JP7566706B2 (ja) | 2013-04-30 | 2021-09-13 | インビボ検体モニタリング環境における電力供給方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2020011070A true JP2020011070A (ja) | 2020-01-23 |
Family
ID=51843896
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016511808A Active JP6568517B2 (ja) | 2013-04-30 | 2014-04-29 | ユーザの連続グルコースモニタリングのための装置、およびユーザの連続検体モニタリングのためのセンサ制御装置を準備する方法 |
JP2019142804A Pending JP2020011070A (ja) | 2013-04-30 | 2019-08-02 | インビボ検体モニタリング環境における電力供給方法、およびインビボ検体モニタリングシステム |
JP2021148432A Active JP7566706B2 (ja) | 2013-04-30 | 2021-09-13 | インビボ検体モニタリング環境における電力供給方法 |
JP2023133921A Ceased JP2023144126A (ja) | 2013-04-30 | 2023-08-21 | インビボ検体モニタリング環境における電力供給方法 |
JP2024152953A Pending JP2024166235A (ja) | 2013-04-30 | 2024-09-05 | インビボグルコースセンサを有するユーザのインビボグルコースモニタリングのための装置 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016511808A Active JP6568517B2 (ja) | 2013-04-30 | 2014-04-29 | ユーザの連続グルコースモニタリングのための装置、およびユーザの連続検体モニタリングのためのセンサ制御装置を準備する方法 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021148432A Active JP7566706B2 (ja) | 2013-04-30 | 2021-09-13 | インビボ検体モニタリング環境における電力供給方法 |
JP2023133921A Ceased JP2023144126A (ja) | 2013-04-30 | 2023-08-21 | インビボ検体モニタリング環境における電力供給方法 |
JP2024152953A Pending JP2024166235A (ja) | 2013-04-30 | 2024-09-05 | インビボグルコースセンサを有するユーザのインビボグルコースモニタリングのための装置 |
Country Status (8)
Country | Link |
---|---|
US (4) | US10213141B2 (ja) |
EP (2) | EP2991552B1 (ja) |
JP (5) | JP6568517B2 (ja) |
CN (2) | CN109222991B (ja) |
AU (4) | AU2014260023B2 (ja) |
CA (1) | CA2909552A1 (ja) |
DE (1) | DE202014011590U1 (ja) |
WO (1) | WO2014179343A1 (ja) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8333714B2 (en) * | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
WO2010138856A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
FI3988470T3 (fi) | 2009-08-31 | 2023-08-18 | Abbott Diabetes Care Inc | Lääkinnällisen laitteen näyttöjä |
EP4333325A3 (en) * | 2010-09-29 | 2024-06-05 | Dexcom, Inc. | Advanced continuous analyte monitoring system |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
WO2014085602A1 (en) | 2012-11-29 | 2014-06-05 | Abbott Diabetes Care Inc. | Methods, devices, and systems related to analyte monitoring |
US9427305B2 (en) | 2013-01-24 | 2016-08-30 | GraftWorx, LLC | Method and apparatus for measuring flow through a lumen |
EP4220654A1 (en) | 2013-03-14 | 2023-08-02 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
US9445445B2 (en) | 2013-03-14 | 2016-09-13 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
JP6568517B2 (ja) | 2013-04-30 | 2019-08-28 | アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. | ユーザの連続グルコースモニタリングのための装置、およびユーザの連続検体モニタリングのためのセンサ制御装置を準備する方法 |
US20140343389A1 (en) * | 2013-05-20 | 2014-11-20 | iMobile Healthcare, LLC | Wireless Monitoring Device |
JP6336336B2 (ja) * | 2014-06-13 | 2018-06-06 | キヤノン株式会社 | 通信装置、制御方法、及びプログラム |
US9858784B2 (en) | 2014-09-29 | 2018-01-02 | Roost, Inc. | Battery-powered device having a battery and loud sound detector using passive sensing |
WO2016081244A1 (en) * | 2014-11-18 | 2016-05-26 | Mc10, Inc. | System, device, and method for electronic device activation |
US10477354B2 (en) | 2015-02-20 | 2019-11-12 | Mc10, Inc. | Automated detection and configuration of wearable devices based on on-body status, location, and/or orientation |
US9924905B2 (en) | 2015-03-09 | 2018-03-27 | Graftworx, Inc. | Sensor position on a prosthesis for detection of a stenosis |
US10531831B2 (en) | 2015-05-14 | 2020-01-14 | Abbott Diabetes Care Inc. | Non-rigid wearable devices |
WO2017095619A1 (en) * | 2015-12-01 | 2017-06-08 | Maxim Integrated Products, Inc. | Systems and methods for correcting lag between sensor temperature and ambient gas temperature |
US11457809B1 (en) * | 2015-12-08 | 2022-10-04 | Verily Life Sciences Llc | NFC beacons for bidirectional communication between an electrochemical sensor and a reader device |
US10602932B2 (en) | 2015-12-16 | 2020-03-31 | Siren Care, Inc. | System and method for detecting inflammation in a foot |
RS65949B1 (sr) | 2016-02-05 | 2024-10-31 | Hoffmann La Roche | Medicinski uređaj za detekciju najmanje jednog analita u telesnoj tečnosti |
FI4241683T3 (fi) | 2016-02-05 | 2024-12-04 | Hoffmann La Roche | Lääkinnällinen laite ainakin yhden analyytin havaitsemiseksi kehon nesteestä |
CN115175014A (zh) | 2016-02-22 | 2022-10-11 | 美谛达解决方案公司 | 贴身传感器系统 |
AU2017245131B2 (en) * | 2016-03-31 | 2020-01-30 | Dexcom, Inc. | Systems and methods for display device and sensor electronics unit communication |
CN109310340A (zh) | 2016-04-19 | 2019-02-05 | Mc10股份有限公司 | 用于测量汗液的方法和系统 |
HUE063052T2 (hu) * | 2016-07-20 | 2023-12-28 | Dexcom Inc | Rendszer és eljárás glükóz adatok vezeték nélküli kommunikációjához |
US9967001B2 (en) * | 2016-07-25 | 2018-05-08 | Verily Life Sciences Llc | Systems and methods for passive radio enabled power gating for a body mountable device |
US10447347B2 (en) | 2016-08-12 | 2019-10-15 | Mc10, Inc. | Wireless charger and high speed data off-loader |
US11406274B2 (en) * | 2016-09-12 | 2022-08-09 | Alio, Inc. | Wearable device with multimodal diagnostics |
WO2018064174A1 (en) | 2016-09-27 | 2018-04-05 | Siren Care, Inc. | Smart yarn and method for manufacturing a yarn containing an electronic device |
EP3558117A1 (en) * | 2016-12-20 | 2019-10-30 | Abbott Diabetes Care Inc. | Systems, devices and methods for wireless communications in analyte monitoring devices |
WO2018125841A1 (en) * | 2016-12-27 | 2018-07-05 | Dexcom, Inc. | Systems and methods for patient monitoring using an hcp - specific device |
CA3055242A1 (en) * | 2017-03-08 | 2018-09-13 | Abbott Diabetes Care Inc. | Systems, devices, and methods for wellness and nutrition monitoring and management using analyte data |
CA3057979A1 (en) * | 2017-03-29 | 2018-10-04 | Graftworx, Inc. | Wearable device with multimodal diagnostics |
CN107329158A (zh) * | 2017-07-11 | 2017-11-07 | 北京博创联动科技有限公司 | 一种车辆定位装置和方法 |
CN111278359A (zh) | 2017-10-26 | 2020-06-12 | 威里利生命科学有限责任公司 | 用于可体戴电子设备的两阶段部署启动唤醒机制 |
RU2755245C1 (ru) | 2017-12-21 | 2021-09-14 | Ф.Хоффманн-Ля Рош Аг | Медицинская система и способ ее изготовления |
CN108652646A (zh) * | 2018-03-15 | 2018-10-16 | 戴兵 | 一种皮下植入式生物传感器装置及系统 |
WO2019183622A1 (en) * | 2018-03-23 | 2019-09-26 | Regenesis Biomedical, Inc. | High-power pulsed electromagnetic field applicator systems |
JPWO2019189437A1 (ja) * | 2018-03-30 | 2021-03-25 | テルモ株式会社 | 薬液投与セット |
US11350857B2 (en) * | 2018-05-03 | 2022-06-07 | Dexcom, Inc. | Systems and methods for activating analyte sensor electronics |
US20200028841A1 (en) * | 2018-06-15 | 2020-01-23 | Proxy, Inc. | Method and apparatus for providing multiple user credentials |
US11038555B2 (en) | 2018-08-06 | 2021-06-15 | Verily Life Sciences Llc | Systems and methods for enabling NFC communications with a wearable biosensor |
US11426101B2 (en) | 2018-07-09 | 2022-08-30 | Verily Life Sciences Llc | Systems and methods for sensors with multimode wireless communications and for enabling NFC communications with a wearable biosensor |
KR102200139B1 (ko) * | 2018-08-07 | 2021-01-08 | 주식회사 아이센스 | 연속혈당측정기의 동작 제어 장치 |
WO2020118696A1 (en) * | 2018-12-14 | 2020-06-18 | Siren Care, Inc. | Method for registration and activation of temperature-sensing garments |
WO2020118694A1 (en) | 2018-12-14 | 2020-06-18 | Siren Care, Inc. | Temperature-sensing garment and method for making same |
CN114025662B (zh) * | 2019-04-18 | 2024-11-29 | 雅培糖尿病护理公司 | 用于在分析物监测环境中处理无线通信的系统、设备和方法 |
EP4364648A3 (en) * | 2019-04-30 | 2024-07-24 | F. Hoffmann-La Roche AG | Continuous analyte sensor with magnetic activation |
TWI699189B (zh) | 2019-05-29 | 2020-07-21 | 華廣生技股份有限公司 | 生物感測裝置及生物感測裝置啟動方法 |
GB201909176D0 (en) * | 2019-06-26 | 2019-08-07 | Royal College Of Art | Wearable device |
WO2021031057A1 (en) * | 2019-08-19 | 2021-02-25 | Medtrum Technologies Inc. | Sensing device |
WO2021052986A1 (en) * | 2019-09-18 | 2021-03-25 | Ascensia Diabetes Care Holdings Ag | Automatic activation of continuous glucose monitoring (cgm) transmitter |
US11833363B2 (en) | 2019-10-25 | 2023-12-05 | Regenesis Biomedical, Inc. | Current-based RF driver for pulsed electromagnetic field applicator systems |
CA3154193A1 (en) * | 2019-10-28 | 2021-05-06 | Daniel M. Bernstein | Systems, devices, and methods for sensor communications |
KR102303553B1 (ko) | 2019-11-21 | 2021-09-23 | 주식회사 아이센스 | 연속혈당측정용 신체 부착 장치 |
EP4157087A1 (en) * | 2020-05-29 | 2023-04-05 | Abbott Diabetes Care Inc. | Analyte sensors and sensing methods for detecting inhibitors of diaphorase |
WO2022047411A1 (en) | 2020-08-31 | 2022-03-03 | Abbott Diabetes Care Inc. | Secured communications in medical monitoring systems |
JP2024502548A (ja) * | 2020-12-31 | 2024-01-22 | アボット ダイアベティス ケア インコーポレイテッド | 医療モニタシステムに埋め込まれたシステム |
EP4301225A1 (en) | 2021-09-28 | 2024-01-10 | Biolinq Incorporated | Microneedle enclosure and applicator device for microneedle array based continuous analyte monitoring device |
CA3234045A1 (en) * | 2021-09-30 | 2023-04-06 | Dexcom, Inc. | Apparatuses, systems, and methods of improving patch performance for a medical device |
CN114067464B (zh) * | 2021-11-09 | 2024-08-20 | 深圳Tcl新技术有限公司 | 智能门锁及其唤醒方法、网络设备、电子设备 |
USD1033641S1 (en) | 2021-12-17 | 2024-07-02 | Biolinq Incorporated | Microneedle array sensor applicator device |
USD1057153S1 (en) | 2022-04-29 | 2025-01-07 | Biolinq Incorporated | Microneedle array sensor applicator device |
WO2024010827A1 (en) * | 2022-07-05 | 2024-01-11 | Biolinq Incorporated | Sensor assembly of a microneedle array-based continuous analyte monitoring device |
WO2024173779A2 (en) * | 2023-02-17 | 2024-08-22 | Abbott Diabetes Care Inc. | Systems, devices, and methods for analyte monitoring |
US20250049355A1 (en) * | 2023-08-01 | 2025-02-13 | Dexcom, Inc. | Systems and methods for providing therapy management recommendations for diabetic patients and patients with liver disease |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005074161A1 (en) * | 2004-01-27 | 2005-08-11 | Altivera L.L.C. | Diagnostic radio frequency identififcation sensors and applications thereof |
WO2005112744A1 (en) * | 2004-05-20 | 2005-12-01 | Digital Angel Corporation | Embedded bio-sensor system |
WO2006114297A1 (de) * | 2005-04-26 | 2006-11-02 | Disetronic Licensing Ag | Energieoptimierte datenübertragung eines medizinischen geräts |
US20070102649A1 (en) * | 2003-04-15 | 2007-05-10 | Sensors For Medicine And Science, Inc. | System and method for attenuating the effect of ambient light on an optical sensor |
US20070232877A1 (en) * | 2006-03-31 | 2007-10-04 | Abbott Diabetes Care, Inc. | Method and system for powering an electronic device |
US20080154101A1 (en) * | 2006-09-27 | 2008-06-26 | Faquir Jain | Implantable Biosensor and Methods of Use Thereof |
WO2008129532A2 (en) * | 2007-04-19 | 2008-10-30 | Mor Research Applications Ltd. | Device system and method for monitoring and controlling blood analyte levels |
US20100270150A1 (en) * | 2009-04-28 | 2010-10-28 | Abbott Diabetes Care Inc. | Smart Sensor Ports and Methods of Using Same |
WO2011025549A1 (en) * | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Medical devices and methods |
US20110282175A1 (en) * | 2010-05-11 | 2011-11-17 | Geissler Randolph K | Wireless molecular sensor system and process |
US20120078071A1 (en) * | 2010-09-29 | 2012-03-29 | Dexcom, Inc. | Advanced continuous analyte monitoring system |
WO2012160163A1 (en) * | 2011-05-25 | 2012-11-29 | Sanofi-Aventis Deutschland Gmbh | Medicament delivery device with cap |
JP2016520379A (ja) * | 2013-04-30 | 2016-07-14 | アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. | エネルギー効率の良い電気機器の作動のためのシステム、装置、および方法 |
Family Cites Families (152)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3431208A (en) | 1965-11-17 | 1969-03-04 | Schering Corp | Denture spray |
US3808686A (en) | 1971-06-28 | 1974-05-07 | Hydro Dent Corp | Hydrophilic coating for dental prostheses |
DE3278334D1 (en) | 1981-10-23 | 1988-05-19 | Genetics Int Inc | Sensor for components of a liquid mixture |
US5682884A (en) | 1983-05-05 | 1997-11-04 | Medisense, Inc. | Strip electrode with screen printing |
CA1219040A (en) | 1983-05-05 | 1987-03-10 | Elliot V. Plotkin | Measurement of enzyme-catalysed reactions |
US5509410A (en) | 1983-06-06 | 1996-04-23 | Medisense, Inc. | Strip electrode including screen printing of a single layer |
US5264104A (en) | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
US5262035A (en) | 1989-08-02 | 1993-11-16 | E. Heller And Company | Enzyme electrodes |
CA2028261C (en) | 1989-10-28 | 1995-01-17 | Won Suck Yang | Non-invasive method and apparatus for measuring blood glucose concentration |
JPH04278450A (ja) | 1991-03-04 | 1992-10-05 | Adam Heller | バイオセンサー及び分析物を分析する方法 |
US5262305A (en) | 1991-03-04 | 1993-11-16 | E. Heller & Company | Interferant eliminating biosensors |
US5593852A (en) | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
US5601435A (en) | 1994-11-04 | 1997-02-11 | Intercare | Method and apparatus for interactively monitoring a physiological condition and for interactively providing health related information |
US5899855A (en) | 1992-11-17 | 1999-05-04 | Health Hero Network, Inc. | Modular microprocessor-based health monitoring system |
US5956501A (en) | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
US5918603A (en) | 1994-05-23 | 1999-07-06 | Health Hero Network, Inc. | Method for treating medical conditions using a microprocessor-based video game |
US5320715A (en) | 1994-01-14 | 1994-06-14 | Lloyd Berg | Separation of 1-pentanol from cyclopentanol by extractive distillation |
US5543326A (en) | 1994-03-04 | 1996-08-06 | Heller; Adam | Biosensor including chemically modified enzymes |
US5628890A (en) | 1995-09-27 | 1997-05-13 | Medisense, Inc. | Electrochemical sensor |
US5748103A (en) * | 1995-11-13 | 1998-05-05 | Vitalcom, Inc. | Two-way TDMA telemetry system with power conservation features |
EP0958495B1 (en) | 1997-02-06 | 2002-11-13 | Therasense, Inc. | Small volume in vitro analyte sensor |
US6270455B1 (en) | 1997-03-28 | 2001-08-07 | Health Hero Network, Inc. | Networked system for interactive communications and remote monitoring of drug delivery |
US6764581B1 (en) | 1997-09-05 | 2004-07-20 | Abbott Laboratories | Electrode with thin working layer |
US6071391A (en) | 1997-09-12 | 2000-06-06 | Nok Corporation | Enzyme electrode structure |
US6736957B1 (en) | 1997-10-16 | 2004-05-18 | Abbott Laboratories | Biosensor electrode mediators for regeneration of cofactors and process for using |
US6579690B1 (en) | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
US6077898A (en) | 1998-01-12 | 2000-06-20 | Seymour Of Sycamore | Temporary stripe marker |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6103033A (en) | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US6197181B1 (en) | 1998-03-20 | 2001-03-06 | Semitool, Inc. | Apparatus and method for electrolytically depositing a metal on a microelectronic workpiece |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) * | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) * | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
GB2337122B (en) | 1998-05-08 | 2002-11-13 | Medisense Inc | Test strip |
US6294281B1 (en) | 1998-06-17 | 2001-09-25 | Therasense, Inc. | Biological fuel cell and method |
US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US6591125B1 (en) | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
CA2351398A1 (en) | 1998-11-30 | 2000-06-08 | Abbott Laboratories | Analyte test instrument having improved calibration and communication processes |
US6773671B1 (en) | 1998-11-30 | 2004-08-10 | Abbott Laboratories | Multichemistry measuring device and test strips |
US6161095A (en) | 1998-12-16 | 2000-12-12 | Health Hero Network, Inc. | Treatment regimen compliance and efficacy with feedback |
GB2351153B (en) | 1999-06-18 | 2003-03-26 | Abbott Lab | Electrochemical sensor for analysis of liquid samples |
EP2322645A1 (en) | 1999-06-18 | 2011-05-18 | Abbott Diabetes Care Inc. | Mass transport limited in vivo analyte sensor |
US6514460B1 (en) | 1999-07-28 | 2003-02-04 | Abbott Laboratories | Luminous glucose monitoring device |
US20060091006A1 (en) | 1999-11-04 | 2006-05-04 | Yi Wang | Analyte sensor with insertion monitor, and methods |
US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
ATE364046T1 (de) | 1999-11-15 | 2007-06-15 | Therasense Inc | Übergangsmetallkomplexe, die über ein bewegliches zwischenglied an ein polymer gebunden sind |
WO2001088524A1 (en) | 2000-05-12 | 2001-11-22 | Therasense, Inc. | Electrodes with multilayer membranes and methods of using and making the electrodes |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US6676816B2 (en) | 2001-05-11 | 2004-01-13 | Therasense, Inc. | Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes |
US6932894B2 (en) | 2001-05-15 | 2005-08-23 | Therasense, Inc. | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
JP2003084101A (ja) | 2001-09-17 | 2003-03-19 | Dainippon Printing Co Ltd | 光学素子用樹脂組成物、光学素子、およびプロジェクションスクリーン |
EP2357245A1 (en) | 2002-02-20 | 2011-08-17 | University Of Georgia Research Foundation, Inc. | Microbial production of alanine |
EP1555934B1 (en) * | 2002-10-11 | 2011-05-25 | Koninklijke Philips Electronics N.V. | Power saving uplink for biosensors |
US7501053B2 (en) | 2002-10-23 | 2009-03-10 | Abbott Laboratories | Biosensor having improved hematocrit and oxygen biases |
US20040118704A1 (en) | 2002-12-19 | 2004-06-24 | Yi Wang | Analyte test intrument having improved versatility |
AU2003303597A1 (en) | 2002-12-31 | 2004-07-29 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
US20130059541A1 (en) | 2003-06-10 | 2013-03-07 | Abbott Diabetes Care Inc. | Wireless Communication Authentication for Medical Monitoring Device |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US7722536B2 (en) | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
CA2896407A1 (en) | 2003-09-11 | 2005-03-24 | Theranos, Inc. | Medical device for analyte monitoring and drug delivery |
US7299082B2 (en) | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
WO2005089103A2 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
JP2008518711A (ja) * | 2004-11-08 | 2008-06-05 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 医療機器の無線バッテリー状態管理 |
CA2587912A1 (en) | 2004-11-19 | 2006-05-26 | Sensormatic Electronics Corporation | Technique and hardware for communicating with backscatter radio frequency identification readers |
US20110190603A1 (en) | 2009-09-29 | 2011-08-04 | Stafford Gary A | Sensor Inserter Having Introducer |
US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US7418285B2 (en) | 2004-12-29 | 2008-08-26 | Abbott Laboratories | Analyte test sensor and method of manufacturing the same |
US20060166629A1 (en) | 2005-01-24 | 2006-07-27 | Therasense, Inc. | Method and apparatus for providing EMC Class-B compliant RF transmitter for data monitoring an detection systems |
US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
KR100638727B1 (ko) | 2005-02-28 | 2006-10-30 | 삼성전기주식회사 | Zigbee 및 불루투스 겸용 송수신기 |
US20090076360A1 (en) | 2007-09-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
DE102005013685A1 (de) * | 2005-03-18 | 2006-09-28 | Roche Diagnostics Gmbh | Bandmagazin für ein Handgerät zur Untersuchung einer Körperflüssigkeit, sowie Handgerät |
US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
US8846154B2 (en) | 2005-06-07 | 2014-09-30 | S.C. Johnson & Son, Inc. | Carpet décor and setting solution compositions |
US8298389B2 (en) | 2005-09-12 | 2012-10-30 | Abbott Diabetes Care Inc. | In vitro analyte sensor, and methods |
US7846311B2 (en) | 2005-09-27 | 2010-12-07 | Abbott Diabetes Care Inc. | In vitro analyte sensor and methods of use |
US20070095661A1 (en) | 2005-10-31 | 2007-05-03 | Yi Wang | Method of making, and, analyte sensor |
US7918975B2 (en) | 2005-11-17 | 2011-04-05 | Abbott Diabetes Care Inc. | Analytical sensors for biological fluid |
US8515518B2 (en) | 2005-12-28 | 2013-08-20 | Abbott Diabetes Care Inc. | Analyte monitoring |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
US7811430B2 (en) | 2006-02-28 | 2010-10-12 | Abbott Diabetes Care Inc. | Biosensors and methods of making |
US7887682B2 (en) | 2006-03-29 | 2011-02-15 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US7801582B2 (en) | 2006-03-31 | 2010-09-21 | Abbott Diabetes Care Inc. | Analyte monitoring and management system and methods therefor |
US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US20070233013A1 (en) | 2006-03-31 | 2007-10-04 | Schoenberg Stephen J | Covers for tissue engaging members |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
WO2007143225A2 (en) | 2006-06-07 | 2007-12-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
US7866026B1 (en) | 2006-08-01 | 2011-01-11 | Abbott Diabetes Care Inc. | Method for making calibration-adjusted sensors |
US7822557B2 (en) | 2006-10-31 | 2010-10-26 | Abbott Diabetes Care Inc. | Analyte sensors and methods |
US20080119705A1 (en) | 2006-11-17 | 2008-05-22 | Medtronic Minimed, Inc. | Systems and Methods for Diabetes Management Using Consumer Electronic Devices |
US7802467B2 (en) | 2006-12-22 | 2010-09-28 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US20080161666A1 (en) | 2006-12-29 | 2008-07-03 | Abbott Diabetes Care, Inc. | Analyte devices and methods |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
JP2008229269A (ja) | 2007-03-23 | 2008-10-02 | Teruya:Kk | Rfidタグ内蔵型グルコースセンサ及び計測システム |
EP3741291A1 (en) | 2007-04-14 | 2020-11-25 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2008128210A1 (en) | 2007-04-14 | 2008-10-23 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
CA2683953C (en) | 2007-04-14 | 2016-08-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
EP2146624B1 (en) | 2007-04-14 | 2020-03-25 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2008130898A1 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
CN101715555A (zh) | 2007-04-27 | 2010-05-26 | 艾伯特糖尿病护理公司 | 使用导电图案的测试带识别 |
US20080281179A1 (en) | 2007-05-08 | 2008-11-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and methods |
US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US20080312845A1 (en) | 2007-05-14 | 2008-12-18 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US10002233B2 (en) | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US7996158B2 (en) | 2007-05-14 | 2011-08-09 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US7768386B2 (en) | 2007-07-31 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US20090036760A1 (en) | 2007-07-31 | 2009-02-05 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US20090294277A1 (en) | 2008-05-30 | 2009-12-03 | Abbott Diabetes Care, Inc. | Method and system for producing thin film biosensors |
US20100198034A1 (en) | 2009-02-03 | 2010-08-05 | Abbott Diabetes Care Inc. | Compact On-Body Physiological Monitoring Devices and Methods Thereof |
US20100198142A1 (en) | 2009-02-04 | 2010-08-05 | Abbott Diabetes Care Inc. | Multi-Function Analyte Test Device and Methods Therefor |
EP3912551B1 (en) | 2009-02-26 | 2023-08-30 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte sensor |
US20100213057A1 (en) | 2009-02-26 | 2010-08-26 | Benjamin Feldman | Self-Powered Analyte Sensor |
US8497777B2 (en) | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
US8372351B2 (en) | 2009-05-29 | 2013-02-12 | Abbott Diabetes Care Inc. | Glucose monitoring system with wireless communications |
US8595607B2 (en) | 2009-06-04 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
CN101577505B (zh) * | 2009-06-16 | 2011-11-16 | 山东大学 | 基于空间电磁能的无线传感器自供能系统及自供能方法 |
US20100326842A1 (en) | 2009-06-30 | 2010-12-30 | Abbott Diabetes Care Inc. | Extruded Electrode Structures and Methods of Using Same |
EP3932309A1 (en) | 2009-07-23 | 2022-01-05 | Abbott Diabetes Care, Inc. | Continuous analyte measurement system |
FI3988470T3 (fi) | 2009-08-31 | 2023-08-18 | Abbott Diabetes Care Inc | Lääkinnällisen laitteen näyttöjä |
WO2011026130A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Inserter device including rotor subassembly |
DK3920471T3 (da) | 2009-09-08 | 2024-02-12 | Abbott Diabetes Care Inc | Fremgangsmåder og fremstillede artikler til hosting af en sikkerhedskritisk applikation på en ukontrolleret databehandlingsindretning |
WO2011041531A1 (en) | 2009-09-30 | 2011-04-07 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US20110082484A1 (en) | 2009-10-07 | 2011-04-07 | Heber Saravia | Sensor inserter assembly having rotatable trigger |
CN102712225B (zh) * | 2009-11-18 | 2015-08-05 | Skf公司 | 具有能量收集器的无线传感器 |
US8828330B2 (en) | 2010-01-28 | 2014-09-09 | Abbott Diabetes Care Inc. | Universal test strip port |
ES2881798T3 (es) | 2010-03-24 | 2021-11-30 | Abbott Diabetes Care Inc | Insertadores de dispositivos médicos y procedimientos de inserción y uso de dispositivos médicos |
WO2011130545A1 (en) | 2010-04-16 | 2011-10-20 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US20110256024A1 (en) | 2010-04-16 | 2011-10-20 | Abbott Diabetes Care Inc. | Modular Analyte Monitoring Device |
JP5820396B2 (ja) | 2010-12-28 | 2015-11-24 | テルモ株式会社 | 血糖測定装置 |
EP3583901A3 (en) * | 2011-02-28 | 2020-01-15 | Abbott Diabetes Care, Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
CN102142721A (zh) * | 2011-04-12 | 2011-08-03 | 南京航空航天大学 | 射频无线供电系统 |
EP3973859A1 (en) | 2011-06-17 | 2022-03-30 | Abbott Diabetes Care, Inc. | Connectors for making connections between analyte sensors and other devices |
CN103906462B (zh) * | 2011-08-03 | 2015-11-25 | 德雷格医疗系统股份有限公司 | 基于吞吐量的活跃模式触发 |
US8971807B2 (en) | 2011-08-12 | 2015-03-03 | Wicentric, Inc. | Systems and methods for low power short range wireless device communication advertisement |
EP4465307A3 (en) | 2011-09-23 | 2025-02-19 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
US20130082821A1 (en) | 2011-10-04 | 2013-04-04 | Roche Diagnostics Operations, Inc. | Proximity-based glucose meter function activation |
JP2013121369A (ja) | 2011-12-09 | 2013-06-20 | Sony Corp | 入力装置及び校正方法 |
DK4056105T3 (da) | 2011-12-11 | 2024-01-02 | Abbott Diabetes Care Inc | Analytsensorindretninger |
CN202837961U (zh) * | 2012-04-01 | 2013-03-27 | 广东金智慧物联网科技有限公司 | 一种基于物联网的能耗信息动态监测系统 |
US9931065B2 (en) | 2012-04-04 | 2018-04-03 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
WO2014018928A1 (en) | 2012-07-27 | 2014-01-30 | Abbott Diabetes Care Inc. | Medical device applicators |
EP4220654A1 (en) * | 2013-03-14 | 2023-08-02 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
US9445445B2 (en) | 2013-03-14 | 2016-09-13 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
EP3744247A1 (en) | 2013-03-15 | 2020-12-02 | Abbott Diabetes Care, Inc. | Medical device data processing and communication methods and systems |
US9590438B2 (en) | 2013-11-05 | 2017-03-07 | Abbott Diabetes Care Inc. | Systems, devices, and methods for control of a power supply connection |
-
2014
- 2014-04-29 JP JP2016511808A patent/JP6568517B2/ja active Active
- 2014-04-29 US US14/265,026 patent/US10213141B2/en active Active
- 2014-04-29 AU AU2014260023A patent/AU2014260023B2/en active Active
- 2014-04-29 CN CN201810946235.8A patent/CN109222991B/zh active Active
- 2014-04-29 DE DE202014011590.7U patent/DE202014011590U1/de not_active Expired - Lifetime
- 2014-04-29 CA CA2909552A patent/CA2909552A1/en active Pending
- 2014-04-29 WO PCT/US2014/035926 patent/WO2014179343A1/en active Application Filing
- 2014-04-29 EP EP14792119.1A patent/EP2991552B1/en active Active
- 2014-04-29 EP EP24202659.9A patent/EP4509047A2/en active Pending
- 2014-04-29 CN CN201480024659.9A patent/CN105188533B/zh active Active
-
2018
- 2018-11-27 US US16/201,688 patent/US11207006B2/en active Active
-
2019
- 2019-01-14 AU AU2019200231A patent/AU2019200231B2/en active Active
- 2019-08-02 JP JP2019142804A patent/JP2020011070A/ja active Pending
-
2021
- 2021-05-18 AU AU2021203193A patent/AU2021203193B2/en active Active
- 2021-09-13 JP JP2021148432A patent/JP7566706B2/ja active Active
- 2021-11-22 US US17/532,427 patent/US20220142523A1/en active Pending
-
2022
- 2022-09-28 US US17/955,312 patent/US11571149B1/en active Active
-
2023
- 2023-08-18 AU AU2023216905A patent/AU2023216905A1/en active Pending
- 2023-08-21 JP JP2023133921A patent/JP2023144126A/ja not_active Ceased
-
2024
- 2024-09-05 JP JP2024152953A patent/JP2024166235A/ja active Pending
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070102649A1 (en) * | 2003-04-15 | 2007-05-10 | Sensors For Medicine And Science, Inc. | System and method for attenuating the effect of ambient light on an optical sensor |
WO2005074161A1 (en) * | 2004-01-27 | 2005-08-11 | Altivera L.L.C. | Diagnostic radio frequency identififcation sensors and applications thereof |
WO2005112744A1 (en) * | 2004-05-20 | 2005-12-01 | Digital Angel Corporation | Embedded bio-sensor system |
WO2006114297A1 (de) * | 2005-04-26 | 2006-11-02 | Disetronic Licensing Ag | Energieoptimierte datenübertragung eines medizinischen geräts |
US20080129486A1 (en) * | 2005-04-26 | 2008-06-05 | Joel Jeckelmann | Energy-Optimised Data Transmission for a Medical Appliance |
US20070232877A1 (en) * | 2006-03-31 | 2007-10-04 | Abbott Diabetes Care, Inc. | Method and system for powering an electronic device |
US20080154101A1 (en) * | 2006-09-27 | 2008-06-26 | Faquir Jain | Implantable Biosensor and Methods of Use Thereof |
WO2008129532A2 (en) * | 2007-04-19 | 2008-10-30 | Mor Research Applications Ltd. | Device system and method for monitoring and controlling blood analyte levels |
US20100270150A1 (en) * | 2009-04-28 | 2010-10-28 | Abbott Diabetes Care Inc. | Smart Sensor Ports and Methods of Using Same |
WO2011025549A1 (en) * | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Medical devices and methods |
US20110282175A1 (en) * | 2010-05-11 | 2011-11-17 | Geissler Randolph K | Wireless molecular sensor system and process |
US20120078071A1 (en) * | 2010-09-29 | 2012-03-29 | Dexcom, Inc. | Advanced continuous analyte monitoring system |
WO2012160163A1 (en) * | 2011-05-25 | 2012-11-29 | Sanofi-Aventis Deutschland Gmbh | Medicament delivery device with cap |
JP2016520379A (ja) * | 2013-04-30 | 2016-07-14 | アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. | エネルギー効率の良い電気機器の作動のためのシステム、装置、および方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2909552A1 (en) | 2014-11-06 |
AU2023216905A1 (en) | 2023-09-07 |
DE202014011590U1 (de) | 2023-01-10 |
EP4509047A2 (en) | 2025-02-19 |
AU2014260023B2 (en) | 2018-12-06 |
EP2991552A4 (en) | 2017-01-11 |
US20190142315A1 (en) | 2019-05-16 |
CN109222991A (zh) | 2019-01-18 |
CN109222991B (zh) | 2022-04-19 |
AU2019200231A1 (en) | 2019-01-31 |
US20150018643A1 (en) | 2015-01-15 |
US20230026648A1 (en) | 2023-01-26 |
CN105188533A (zh) | 2015-12-23 |
US20220142523A1 (en) | 2022-05-12 |
AU2021203193B2 (en) | 2023-05-18 |
JP2023144126A (ja) | 2023-10-06 |
EP2991552B1 (en) | 2024-11-27 |
US11571149B1 (en) | 2023-02-07 |
JP6568517B2 (ja) | 2019-08-28 |
US11207006B2 (en) | 2021-12-28 |
JP2024166235A (ja) | 2024-11-28 |
CN105188533B (zh) | 2018-09-14 |
AU2019200231B2 (en) | 2021-02-18 |
AU2021203193A1 (en) | 2021-06-10 |
JP2016520379A (ja) | 2016-07-14 |
AU2014260023A1 (en) | 2015-11-05 |
JP2022001267A (ja) | 2022-01-06 |
EP2991552A1 (en) | 2016-03-09 |
WO2014179343A1 (en) | 2014-11-06 |
JP7566706B2 (ja) | 2024-10-15 |
US10213141B2 (en) | 2019-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7566706B2 (ja) | インビボ検体モニタリング環境における電力供給方法 | |
US11563812B2 (en) | Management of multiple devices within an analyte monitoring environment | |
CN102307517B (zh) | 紧凑型在体生理监测装置及其方法 | |
JP2024036395A (ja) | 検体センサに関連するノートおよびイベントログ情報 | |
JP2021522900A (ja) | 使い捨てベース内に位置するバッテリを有する分析物センサシステムに関するシステムおよび方法 | |
EP2146622B1 (en) | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device | |
KR20240125666A (ko) | 복수의 분석물을 감지하기 위한 방법들 및 시스템들 | |
JP2024509675A (ja) | 携帯型の生理学的パラメータモニタリング及び治療介入のシステムのためのネットワーク物理層構成 | |
US20220167135A1 (en) | Test sensor systems and methods using the same | |
JP2024504174A (ja) | ケトンセンサに関連するシステム、デバイス、および方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190807 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190902 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190902 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200826 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200902 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20201202 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210202 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20210512 |